Sites:

USA:      Total 2,5000 sf synthesis, analytical and kilogram scale-up laboratories equipped with 70 fume hoods and state-of-the-art instruments.

Wuhan:  41,000 sf synthesis, analytical and kilogram scale-up, API solid state and formulation development laboratories equipped with 120 fume hoods and state-of-the-art instruments.

Dalian:   Process development and kilogram scale-up laboratories; Tonnage manufacturing

Heilongjiang: A 50 acres modern manufacture factory based on continuous processing, under construction

 

Special reaction suites: 

continuous (including homogeneous and fixed bed)

Photochemistry

High temperature, high pressure and high vacuum reaction systems.

 

Instrumentation:

GC; HPLC; GC-MS; LC-MS; Preparative LC; NMR; GPC; TGA/DSC; etc.

 

Capacity:

Laboratory research, kilograms scale-up, commercial manufacturing

Technical Team:

 

Total number of technical personnel: 140

PhD: 40 

Renowned experts: 5

Quality professionals: 25%

Having background and experience of Chinese pharmaceutical and chemical industry: 60%

Having background and experience of USA pharmaceutical and chemical industry: 40%

 

Management Team:

 

Dr. Aaron Shen: 

Expert in Polymer Chemistry and Global Business Strategy and Marketing

Aaron obtained his PhD from Virginia Tech in 1992. He worked as director of biomaterials at W. L. Gore; CEO for Chiral Quest China; Chief Strategy Officer for Chemphy. He is senior visiting scholar of Chinese Academy of Sci. Awards he received include Shanghai Magnolia Award; Dalian Friendship Award; Champion of 1995 Toastmaster humorous speech contest for USA District 18. Aaron oversees company’s business strategy.

 

Dr. Paul Wei: 

Expert in Organic and Medicinal Chemistry

Paul obtained his PhD from U. of Missouri in 2002; he worked as post-doctor fellow at U. of Iowa; R&D director at Adesis Inc. He has over 20 years of CDMO business. Currently he is president of Affinity Research Chemicals In and Chairman of Affinity (Wuhan) Ltd.

 

Alicia Ren:

Alicia graduated from Dalian U. of Tech. in 2004 with a major in ChemE&Tech. She has nearly 20 years of working experience in the field of pharmaceutical and chemical industry as senior account manager, assistant to general manager, business director, etc. She is currently the business director of Affinity China and the general manager of Affinity (Wuhan) Ltd.

Michael Zhang:

Mr. Zhang graduated from Wuhan Inst. of Tech. in 2012 with a major in ChemE&Tech. He has more than ten years of experience in the field of pharmaceutical and chemical industry as organic synthesis chemist, sales manager, assistant to general manager, etc. He is currently the VP operation of Affinity (Wuhan) and also in charge of BD for Affinity China.

 

Dr. Jimmy Huang: 

Expert in Organic and Processing Chemistry

Dr. Huang received his PhD from a joint program of Zhejiang U of Ind and Beijing Inst. of Chem. He is CTO of Affinity (Wuhan) Ltd. He is a young creative and experienced chemist with full of energy and passion for the job.

 

 

 

Mr. Chuanbo Li: 

Expert in Chemical Manufacturing and EHS Management

Our VP manufacture is a “big shot” of chemical manufacturing. He has life-time experiences as manufacture and EHS leadership. He successfully led to build and managed three middle-to-large size chemical/pharmaceutical manufacture plants.

 

Advisory Board:

 

Prof. Xinquan Hu: 

Expert in Organic Synthesis and Chemical Processing

Prof. Hu obtained his PhD from a joint program of Penn State and Dalian Inst of ChemPhy in 1999. He worked as CTO for Trico and CTO for Chemphy. He received Eli Lilly Award. He is the translation author of popular book “The Art of Process Chemistry”. He provides guidance for process chemistry.

 

Dr. Tony Zhang: 

Expert in Organic Chemistry and Pharmaceutical Chemistry

Tony obtained his PhD from Purdue U in 1983. He worked as chief scientist at Lilly Small Molecule Dept; GM of Lilly China R&D Center; He is founder and current CEO of Tyligand BioTech. Awards include Lilly Board Award; Purdue Excellent Alumni Award; Indiana Excellent Chinese American Award. He is previous VP of Pudong New Drug Development Committee and Chuanhui Scholar. He provides guidance for organic and medicinal chemistry.

 

Affinity always stands at the forefront of global new technology!

Affinity owns proprietary technologies and patents.

Affinity Core Technology

Affinity Specialty

The world's top technical team with global experiences

Synthesis, process development and scale-up technology

Continuous process

Total solution one-stop CDMO

Single molecular weight PEG products: PrecisePEG^TM